Effect of perioperative β blockade in patients with diabetes undergoing major non-cardiac surgery: Randomised placebo controlled, blinded multicentre trial

British Medical Journal

Volumn 332, Issue 7556, 2006, Pages 1482-1485

  Juul, A B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

METOPROLOL; PLACEBO; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG SAFETY; FEMALE; FOLLOW UP; HEART DEATH; HEART HEMODYNAMICS; HEART INFARCTION; HEART RATE; HOSPITAL DEPARTMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORBIDITY; MULTICENTER STUDY; OPERATION DURATION; PATIENT COMPLIANCE; PERIOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SURGICAL MORTALITY; SURGICAL RISK; SURGICAL TECHNIQUE; SUSTAINED DRUG RELEASE; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; UNSPECIFIED SIDE EFFECT; UNSTABLE ANGINA PECTORIS; DELAYED RELEASE FORMULATION; DOUBLE BLIND PROCEDURE; HEMODYNAMICS; MIDDLE AGED; PEROPERATIVE CARE; SURGERY;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; DELAYED-ACTION PREPARATIONS; DIABETES COMPLICATIONS; DOUBLE-BLIND METHOD; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INTRAOPERATIVE CARE; MALE; METOPROLOL; MIDDLE AGED; PATIENT COMPLIANCE; SURGICAL PROCEDURES, OPERATIVE; TREATMENT OUTCOME;

EID: 33745713564     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38835.648194.4F     Document Type: Article

References (9)

1. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for non-cardiac surgery-executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to update the 1996 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). Circulation 2002;105:1257-67.
2. Devereaux PJ, Scott Beattie W, Choi PT-L, Badner NH, Guyatt G, Villar JC, et al. How strong is the evidence for the use of perioperative β blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ 2005;331:313-21.
3. POBBLE Trial investigators. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 2005;41:602-9.
4. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996;335:1713-20.
5. Juul AB, Wetterslev J, Kofoed-Enevoldsen A, Jensen G, Callesen T, Gluud C, The DIPOM Group. The diabetic postoperative mortality and morbidity (DIPOM) trial: rationale and design of a multicenter, randomised, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery. Am Heart J 2004;147:677-83.
6. Juul AB, Wetterslev J, Kofoed-Enevoldsen A. Long-term postoperative mortality in diabetic patients undergoing major non-cardiac surgery. Eur J Anaesthesiol 2004;21:523-9.
7. 2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome. JAMA 2005;294:1526-33.
8. Poldermans D, Boersma E, Bax JJ. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999;341:1789-94.
9. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005;353:349-61.